COVID-19 Vaccine Booster Guidance

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

COVID-19 Vaccine Booster Guidance

September 8, 2021

In an effort to clear up any confusion among providers about whether or not they can offer booster doses of COVID-19 vaccine at the present time, the Maine Immunization Program is sending out the following key elements as a reminder to all COVID-19 providers:


  • Administration of the product off label may not be covered under the PREP Act or the PREP Act declaration; therefore, providers may not have immunity from claims.
  • Individuals who receive an off-label dose may not be eligible for compensation under the Countermeasures Injury Compensation Program after a possible adverse event.
  • CDC has defined the scope of the CDC COVID-19 Vaccination Program in terms of how the USG-provided vaccines may be used in the program.  Providers giving off-label doses would be in violation of the CDC Program provider agreement potentially impacting their ability to remain a provider in the CDC program.
  • Administration fees may not be reimbursable by payers.